Carmot Therapeutics Funding: $55M Raised, Series A (2023)
Carmot Therapeutics is based in San Francisco, California. It has raised $55M in total funding. Latest round: Series A.
Carmot Therapeutics funding overview
Carmot Therapeutics is based in San Francisco, California. Carmot Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2023. The round record for Carmot Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include The Column Group, Dimension, Horizons Ventures. 3 distinct backers are named across the disclosed rounds.
Carmot Therapeutics at a glance
Total raised
$55M
Latest round
Series A
Latest round date
December 2023
Headquarters
San Francisco, California
Notable investors
The Column Group, Dimension, Horizons Ventures
Frequently asked about Carmot Therapeutics funding
How much has Carmot Therapeutics raised?
Carmot Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Carmot Therapeutics?
The Column Group, Dimension, Horizons Ventures are named among the investors backing Carmot Therapeutics.
What was the latest Carmot Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2023.
Where is Carmot Therapeutics based?
Carmot Therapeutics is based in San Francisco, California.
When did Carmot Therapeutics last raise?
The last disclosed Carmot Therapeutics round closed in December 2023 at Series A.
Totals shown for Carmot Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.
